2026年2月23日,3名阿皮亚姆动物保健内部人员出售了1 130万股,价值达989万澳元。 On Feb. 23, 2026, three Apiam Animal Health insiders sold over 11.3 million shares for ~A$9.89 million.

2026年2月23日, 阿皮亚姆动物健康组织(Andrew Vizard)、布鲁斯·狄克逊和理查德·丹尼斯(Rick Dennis)三名内幕人士共售出1 130多万股,每股0.88澳元,收益约为989万澳元。 On February 23, 2026, three insiders at Apiam Animal Health—Andrew Vizard, Bruce Dixon, and Richard (Rick) Dennis—sold a combined total of over 11.3 million shares at A$0.88 per share, generating approximately A$9.89 million in proceeds. 该公司在澳大利亚提供兽医产品和服务,报告市场上限为7 666万美元,债务与股本比率为83.41,物价与收益比率为15.28。 The company, which provides veterinary products and services in Australia, reported a market cap of $76.66 million, a debt-to-equity ratio of 83.41, and a price-to-earnings ratio of 15.28. 它最近支付了每股0.10澳元的临时红利,因此报告的股利收益为1,143%,付款比率为66.67%。 It recently paid an interim dividend of A$0.10 per share, resulting in a reported dividend yield of 1,143% and a payout ratio of 66.67%. 销售是在乳制品、饲料、猪和伴生动物部分持续经营过程中进行的,这些服务包括诊断、定制疫苗、远程医疗和畜群管理软件。 The sales occurred amid ongoing operations across dairy, feedlots, pigs, and companion animal segments, with services including diagnostics, custom vaccines, telemedicine, and herd management software. 没有提供关于内幕人员动机或公司财务前景的补充情况。 No additional context on the insiders' motivations or the company’s financial outlook was provided.